Episode Details

Why do so many patients — not just those with endometriosis — end up cycling through specialists, labs, and prescriptions without ever getting a real answer? In this episode, Dr. Kylie Burton and Jessica Brickie sit down with gynecologist and women's health advocate Dr. Joelle Osias to make the case for a different model of medicine altogether: one built on root causes, individualized labs, and tools like peptides and GLP-1s that fall outside the standard playbook.

Dr. Osias uses her own path — from Stanford- and Johns Hopkins-trained gynecologist to outspoken advocate for personalized medicine — to explain why "standard of care" so often means algorithmic, one-size-fits-all treatment, and what changes when a physician is willing to look at the whole body instead of just their assigned specialty. She and the hosts trace that thinking through endometriosis as a case study (its whole-body, autoimmune nature, the limits of hormones and repeat surgery), but the conversation ranges well beyond it — into gut health and food sensitivities, thyroid testing gaps, vitamin D, peptides like BPC-157 and KPV, and the growing off-label use of GLP-1s for inflammation, PCOS, cardiovascular risk, and even cancer prevention. Jessica also shares her own diagnosis story from 1990, grounding the discussion in just how far — and how little — medicine has moved in three decades.

Whether or not endometriosis is part of your story, this episode is really about a bigger question: what does it look like to treat the whole patient, and what tools exist for that once you step outside the standard of care?

What You'll Learn

• Why "standard of care" is often algorithmic by design — and what gets lost when medicine treats patients as a protocol instead of an individual
• How Dr. Osias started incorporating peptides (including BPC-157 and KPV) into patient care, and the regulatory hurdles around off-label and non-FDA-indicated treatments
• GLP-1 microdosing for inflammation, PCOS, cardiovascular risk, and more — including why standard pharmaceutical dosing doesn't fit every patient
• The gut-immune connection, food sensitivities, and why 80% of the immune system lives in the gut
• Commonly missed labs: free T3, reverse T3, vitamin D, ferritin — and why standard panels can miss real dysfunction
• The challenges of accessing peptide and GLP-1 therapy for adolescent patients
• Endometriosis as a case study: what it actually is, why it's better understood as a whole-body autoimmune-inflammatory condition, and why surgery and hormones alone so often fall short
• The risks of early hysterectomy and why Dr. Osias considers it a last resort, not a first-line fix
• Why Dr. Osias believes personalized medicine, not algorithmic standard-of-care protocols, is the future of healthcare — for women and men alike

Segment Breakdown

• What Endometriosis Really Is — Redefining endometriosis as a whole-body, autoimmune-inflammatory condition
• Genetics, Toxins & Immune Clues — Family patterns, environmental exposures, and immune dysfunction
• Why Surgery Alone Falls Short — The limits of the "medicate and operate" cycle
• Standard of Care & the Patient Runaround — How patients get bounced between specialists without answers
• Learning Peptides Beyond the Rules — Dr. Osias's journey into BPC-157, patient-driven discovery, and the FDA approval process
• GLP-1 Microdosing for Inflammation — Off-label use, dosing challenges, and stigma around GLP-1 therapy
• Gut, Thyroid, Vitamin D & Root Causes — The labs conventional care often skips
• Peptides for Teens: Safety & Access — Navigating age restrictions and adolescent care
• Personalized Care & Patient Agency — Why patients need to be partners, not passengers, in